Intervene Immune
PrivateLast Round
Seed
Dec 27, 2019
Total Funding Raised
$471,000
Company Overview
Intervene Immune is a biotechnology company that develops immuno-therapies and diagnostics designed for thymus regeneration and age-related immune system decline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intervene Immune Comparables
Compare Intervene Immune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TECregen | 77% | |
| United Therapeutics | 77% | |
| Tolerance Bio, Inc. | 68% | |
Intervene Immune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 27, 2019 |
Intervene Immune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 27, 2019
$471K raised from Longevitytech.fund and quadraScope Ventures.
Intervene Immune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intervene Immune's valuation, stock price, and market status.